1.Complete Mesocolic Excision With Central Vascular Ligation in Comparison With Conventional Surgery for Patients With Colon Cancer – The Experiences at Two Centers.
Mohamed ABDELKHALEK ; Ahmed SETIT ; Francesco BIANCO ; Andrea BELLI ; Adel DENEWER ; Tamer Fady YOUSSEF ; Armando FALATO ; Giovanni Maria ROMANO
Annals of Coloproctology 2018;34(4):180-186
PURPOSE: Revolutions have occurred over the last 3 decades in the management of patients with colorectal cancer. Most advances were in rectal cancer surgery, especially after the introduction of the total mesorectal excision (TME) by Heald. However, no parallel advances regarding colon cancer surgeries have occurred. In 2009, Hohenberger introduced a new concept trying to translate the survival advantages of TME to patients with colon cancer. This relatively new concept of a complete mesocolic excision (CME) with central vascular ligation (CVL) in the management of patients with colon cancer represents an evolution in operative technique. We performed a comparative study between CME with CVL and conventional surgery for patients with colon cancer at Italian and Egyptian cancer centers, considering surgical quality and clinical outcome. METHODS: Seventy-nine Egyptian patients underwent conventional surgery (non-CME group) while 52 Italian patients underwent CME with sharp dissection between the embryological planes and CVL of the supplying vessels (CME group). RESULTS: Significantly better results were observed in terms of lymph node yield (CME group: 22.5 vs. non-CME group: 12; P < 0.0001) and lymph node ratio (CME group: 0.03 vs. non-CME group: 0.22; P < 0.0001). Regarding surgical morbidity, no significant difference was noted (CME group: 2 vs. non-CME group: 5; P < 0.702). CONCLUSION: CME appears to be a safe procedure when performed by experienced hands through proper embryological planes. It also provides a superior specimen, with a higher lymph node yield, which consequently affects the lymph node ratio. Eventually, CME with CVL should be increasingly adopted and studied more deeply.
Colon*
;
Colonic Neoplasms*
;
Colorectal Neoplasms
;
Hand
;
Humans
;
Ligation*
;
Lymph Nodes
;
Mesocolon
;
Rectal Neoplasms
2.The Burden of Agoraphobia in Worsening Quality of Life in a Community Survey in Italy
Antonio PRETI ; Martina PIRAS ; Giulia COSSU ; Elisa PINTUS ; Mirra PINTUS ; Goce KALCEV ; Federico CABRAS ; Maria Francesca MORO ; Ferdinando ROMANO ; Matteo BALESTRIERI ; Filippo CARACI ; Liliana DELL’OSSO ; Guido Di SCIASCIO ; Filippo DRAGO ; Maria Carolina HARDOY ; Rita RONCONE ; Carlo FARAVELLI ; Mario MUSU ; Gabriele FINCO ; Antonio Egidio NARDI ; Mauro Giovanni CARTA
Psychiatry Investigation 2021;18(4):277-283
Objective:
Current nosology redefined agoraphobia as an autonomous diagnosis distinct from panic disorder. We investigated the lifetime prevalence of agoraphobia, its association with other mental disorders, and its impact on the health-related quality of life (HR-QoL).
Methods:
Community survey in 2,338 randomly selected adult subjects. Participants were interviewed with the Advanced Neuropsychiatric Tools and Assessment Schedule (ANTAS), administered by clinicians. The diagnoses were based on the ICD-10 criteria. The Short-Form Health Survey (SF-12) was used to quantify HR-QoL.
Results:
In the sample, 35 subjects met the criteria for agoraphobia (1.5%), with greater prevalence among women (2.0%) than men (0.9%): odds ratio (OR) 2.23; 95% CI: 1.0-5–2. Agoraphobia was more often seen among those with (n=26; 1.1%) than without (n=9; 0.4%) panic disorder: OR=8.3; 2.9–24.4. Co-morbidity with other mental disorders was substantial. The mean score of SF-12 in people with agoraphobia was 35.2±7.8, with similar levels of HR-QoL in people with (35.3±7.9) or without (34.8±7.3) panic disorder: ANOVA: F(1;33)=0.0; p=1.00.
Conclusion
One out of seventy people may suffer from agoraphobia in their lifetime. The attributable burden in terms of HR-QoL is substantial and comparable to the one observed for chronic mental disorders such as major depression, post-traumatic stress disorder, or obsessive-compulsive disorder.
3.The Burden of Agoraphobia in Worsening Quality of Life in a Community Survey in Italy
Antonio PRETI ; Martina PIRAS ; Giulia COSSU ; Elisa PINTUS ; Mirra PINTUS ; Goce KALCEV ; Federico CABRAS ; Maria Francesca MORO ; Ferdinando ROMANO ; Matteo BALESTRIERI ; Filippo CARACI ; Liliana DELL’OSSO ; Guido Di SCIASCIO ; Filippo DRAGO ; Maria Carolina HARDOY ; Rita RONCONE ; Carlo FARAVELLI ; Mario MUSU ; Gabriele FINCO ; Antonio Egidio NARDI ; Mauro Giovanni CARTA
Psychiatry Investigation 2021;18(4):277-283
Objective:
Current nosology redefined agoraphobia as an autonomous diagnosis distinct from panic disorder. We investigated the lifetime prevalence of agoraphobia, its association with other mental disorders, and its impact on the health-related quality of life (HR-QoL).
Methods:
Community survey in 2,338 randomly selected adult subjects. Participants were interviewed with the Advanced Neuropsychiatric Tools and Assessment Schedule (ANTAS), administered by clinicians. The diagnoses were based on the ICD-10 criteria. The Short-Form Health Survey (SF-12) was used to quantify HR-QoL.
Results:
In the sample, 35 subjects met the criteria for agoraphobia (1.5%), with greater prevalence among women (2.0%) than men (0.9%): odds ratio (OR) 2.23; 95% CI: 1.0-5–2. Agoraphobia was more often seen among those with (n=26; 1.1%) than without (n=9; 0.4%) panic disorder: OR=8.3; 2.9–24.4. Co-morbidity with other mental disorders was substantial. The mean score of SF-12 in people with agoraphobia was 35.2±7.8, with similar levels of HR-QoL in people with (35.3±7.9) or without (34.8±7.3) panic disorder: ANOVA: F(1;33)=0.0; p=1.00.
Conclusion
One out of seventy people may suffer from agoraphobia in their lifetime. The attributable burden in terms of HR-QoL is substantial and comparable to the one observed for chronic mental disorders such as major depression, post-traumatic stress disorder, or obsessive-compulsive disorder.